PACIRA PHARMACEUTICALS INC's ticker is and the CUSIP is 695127AB6. A total of 12 filers reported holding PACIRA PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $6,934,000 | -8.0% | 4,997,000 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $7,536,000 | -6.3% | 4,997,000 | 0.0% | 0.00% | -20.0% |
| Q2 2016 | $8,045,000 | -27.5% | 4,997,000 | 0.0% | 0.01% | -28.6% |
| Q1 2016 | $11,093,000 | -29.5% | 4,997,000 | 0.0% | 0.01% | -30.0% |
| Q4 2015 | $15,724,000 | +46.0% | 4,997,000 | -16.7% | 0.01% | +25.0% |
| Q3 2015 | $10,768,000 | -36.6% | 5,997,000 | -0.1% | 0.01% | -33.3% |
| Q2 2015 | $16,996,000 | -6.2% | 6,001,000 | +20.0% | 0.01% | -7.7% |
| Q1 2015 | $18,125,000 | -1.1% | 5,001,000 | -0.4% | 0.01% | +8.3% |
| Q4 2014 | $18,328,000 | – | 5,019,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WHITEBOX ADVISORS LLC | 22,336,000 | $38,990,000 | 1.74% |
| EQUITEC SPECIALISTS, LLC | 1,500,000 | $2,618,000 | 1.13% |
| TFG Asset Management GP Ltd | 1,200,000 | $2,080,000 | 1.00% |
| WOLVERINE ASSET MANAGEMENT LLC | 21,393,000 | $37,296,000 | 0.88% |
| Verition Fund Management LLC | 1,200,000 | $2,101,000 | 0.55% |
| PALISADE CAPITAL MANAGEMENT, LP | 1,338,000 | $2,323,000 | 0.07% |
| Citadel Advisors | 33,214,000 | $57,657,000 | 0.06% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 1,200,000 | $2,087,000,000 | 0.04% |
| Visium Asset Management, LP | 1,500,000 | $2,607,000 | 0.04% |
| ROYAL BANK OF CANADA | 5,997,000 | $10,768,000 | 0.01% |